200 related articles for article (PubMed ID: 29779437)
41. Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS.
Echeverri A; Naranjo-Escobar J; Posso-Osorio I; Aguirre-Valencia D; Zambrano D; Castaño GL; Martínez JD; Cañas CA; Tobón GJ
Lupus; 2018 Jun; 27(7):1130-1139. PubMed ID: 29540108
[TBL] [Abstract][Full Text] [Related]
42. Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis.
Ajmani S; Singh H; Chaturvedi S; Mishra R; Rai MK; Jain A; Misra DP; Agarwal V
Clin Rheumatol; 2019 Apr; 38(4):997-1005. PubMed ID: 30446886
[TBL] [Abstract][Full Text] [Related]
43. Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?
Eberhard OK; Langefeld I; Kuse ER; Brunkhorst FM; Kliem V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
Clin Transplant; 1998 Jun; 12(3):206-11. PubMed ID: 9642511
[TBL] [Abstract][Full Text] [Related]
44. Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosus.
Hind CR; Ng SC; Feng PH; Pepys MB
Ann Rheum Dis; 1985 Apr; 44(4):260-1. PubMed ID: 3985691
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic accuracies of procalcitonin and C-reactive protein for bacterial infection in patients with systemic rheumatic diseases: a meta-analysis.
Song GG; Bae SC; Lee YH
Clin Exp Rheumatol; 2015; 33(2):166-73. PubMed ID: 25602442
[TBL] [Abstract][Full Text] [Related]
46. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J
Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711
[TBL] [Abstract][Full Text] [Related]
47. Procalcitonin and albumin as prognostic biomarkers in elderly patients with a risk of bacterial infection.
Higashikawa T; Okuro M; Ishigami K; Mae K; Sangen R; Mizuno T; Usuda D; Saito A; Kasamaki Y; Fukuda A; Saito H; Morimoto S; Kanda T
J Int Med Res; 2018 Jul; 46(7):2606-2614. PubMed ID: 29658355
[TBL] [Abstract][Full Text] [Related]
48. Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode?
Wang KC; Liu PH; Yu KH; Weng YM; Ng CJ; Chiu TF; Chen SY
Immunol Lett; 2017 May; 185():84-89. PubMed ID: 28286229
[TBL] [Abstract][Full Text] [Related]
49. The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.
Littlejohn E; Marder W; Lewis E; Francis S; Jackish J; McCune WJ; Somers EC
Lupus; 2018 Jun; 27(7):1123-1129. PubMed ID: 29546774
[TBL] [Abstract][Full Text] [Related]
50. Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein.
Shimetani N; Shimetani K; Mori M
Scand J Clin Lab Invest; 2004; 64(5):469-74. PubMed ID: 15276911
[TBL] [Abstract][Full Text] [Related]
51. Interrelationships Between Serum Levels of Procalcitonin and Inflammatory Markers in Patients Who Visited a General Medicine Department.
Araki J; Oka K; Yamamoto K; Hanayama Y; Tokumasu K; Hagiya H; Ogawa H; Itoshima K; Otsuka F
Acta Med Okayama; 2021 Jun; 75(3):299-306. PubMed ID: 34176933
[TBL] [Abstract][Full Text] [Related]
52. Procalcitonin in patients with acute and chronic renal insufficiency.
Steinbach G; Bölke E; Grünert A; Störck M; Orth K
Wien Klin Wochenschr; 2004 Dec; 116(24):849-53. PubMed ID: 15690970
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and prognostic value of procalcitonin and C-reactive protein in malnourished children.
Page AL; de Rekeneire N; Sayadi S; Aberrane S; Janssens AC; Dehoux M; Baron E
Pediatrics; 2014 Feb; 133(2):e363-70. PubMed ID: 24446443
[TBL] [Abstract][Full Text] [Related]
54. Procalcitonin and C-Reactive Protein for Bacterial Infection Diagnosis in Elderly Patients After Traumatic Orthopedic Surgery.
Villain C; Chenevier-Gobeaux C; Cohen-Bittan J; Ray P; Epelboin L; Verny M; Riou B; Khiami F; Vallet H; Boddaert J
J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):2008-2014. PubMed ID: 31549176
[TBL] [Abstract][Full Text] [Related]
55. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study.
Chan YL; Tseng CP; Tsay PK; Chang SS; Chiu TF; Chen JC
Crit Care; 2004 Feb; 8(1):R12-20. PubMed ID: 14975050
[TBL] [Abstract][Full Text] [Related]
56. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.
Arkader R; Troster EJ; Lopes MR; Júnior RR; Carcillo JA; Leone C; Okay TS
Arch Dis Child; 2006 Feb; 91(2):117-20. PubMed ID: 16326799
[TBL] [Abstract][Full Text] [Related]
57. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.
ter Borg EJ; Horst G; Limburg PC; van Rijswijk MH; Kallenberg CG
J Rheumatol; 1990 Dec; 17(12):1642-8. PubMed ID: 2084238
[TBL] [Abstract][Full Text] [Related]
58. Procalcitonin and C-reactive Protein Levels as Biomarkers to Determine Gastrointestinal Involvement in Adult Henoch-Schönlein Purpura Patients.
Wang Q; Liu W; Zhang L
Acta Reumatol Port; 2020; 45(1):34-38. PubMed ID: 32572013
[TBL] [Abstract][Full Text] [Related]
59. Differentiating flare and infection in febrile lupus patients: Derivation and validation of a calculator for resource constrained settings.
Mehta P; Singh K; Anand S; Parikh A; Patnaik A; Chatterjee R; Lawrence A; Tripathy SR; Kavadichanda C; Rajasekhar L; Vs N; Das B; Amita A
Lupus; 2022 Sep; 31(10):1254-1262. PubMed ID: 35786213
[No Abstract] [Full Text] [Related]
60. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.
de Kruif MD; Limper M; Gerritsen H; Spek CA; Brandjes DP; ten Cate H; Bossuyt PM; Reitsma PH; van Gorp EC
Crit Care Med; 2010 Feb; 38(2):457-63. PubMed ID: 20083920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
